Pörssitiedote05.10.2023 klo 09.30Learning 2 Sleep Signs Agreement to Acquire YouGo Healthplan AB – Strengthens Customer Offering with Analytical Tools
Lehdistötiedote15.03.2023 klo 09.30Learning 2 Sleep L2S AB begins collaboration with Funmed AB, Europe's largest medical clinic in precision health and functional medicine
Lehdistötiedote31.01.2023 klo 09.30Learning 2 Sleep L2S AB begins collaboration with the digital corporate health company Wellbefy
Lehdistötiedote16.11.2022 klo 09.30Learning to Sleep's treatment of sleep problems is superior to equivalent treatments according to a study conducted by Sweden's largest center for medical research
Lehdistötiedote11.10.2022 klo 09.30Learning 2 Sleep L2S AB start collaboration with the eating disorder company Progress Me
Lehdistötiedote29.09.2022 klo 09.30Learning 2 Sleep L2S AB - The management and parts of the board increase their holdings
Pörssitiedote24.08.2022 klo 16.00Correction: Quarterly report Q2 2022: Continued development but also challenges
Lehdistötiedote24.08.2022 klo 15.50Correction: Quarterly report Q2 2022: Continued development but also challenges
Lehdistötiedote24.08.2022 klo 15.00Quarterly report Q2 2022: Continued development but also challenges
Lehdistötiedote16.06.2022 klo 10.50Learning to Sleep announces the outcome of the exercise of warrants of series TO1
Lehdistötiedote14.06.2022 klo 09.30Learning 2 Sleep represents the Nordic region at HIMSS22 in Helsinki
Lehdistötiedote10.06.2022 klo 10.00Learning 2 Sleep completes the acquisition of the intestinal flora analysis company Symbio Me AB
Lehdistötiedote08.06.2022 klo 09.30The first results from Karolinska Institutet research study show that Learning 2 Sleep's treatment works